Latest updates for 23Andme Inc.
Fresh curated links around 23andMe Inc. are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
- California sues 23andMe over large 2023 data breach
- 23andMe owes customers money again: Who’s eligible for the new $47 million bankruptcy payment
- California attorney general sues 23andMe for data breach
Post angles to try
Fresh articles and ideas
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
23andMe owes customers money again: Who’s eligible for the new $47 million bankruptcy payment
The 23andMe hacking saga has a new development, courtesy of a multi-million dollar payout to its victims. On Tuesday, July 7, a U.S. bankruptcy judge ordered 23andMe’s parent c...
California attorney general sues 23andMe for data breach
California Atty. Gen. Rob Bonta filed suit against the genetic testing company formerly known as 23andMe for failing to protect its customers' data.
23andMe Sued by California Over Massive 2023 Data Breach
Attorney general calls the company's security measures "lax" and says it failed to adequately investigate warnings its systems had been compromised.
23andMe inherits lawsuit over 'disturbing' DNA data breach
California AG claims genetics biz downplayed 2023 mega-leak while paying ransom to attacker
Court Approves $46 Million 23andMe Settlement For 2023 Data Breach Victims
Roughly half of all 23andMe customers were impacted by the breach.
Claimants of 23andMe Data Breach to Get $46.75M in Settlement Deal
The administrator of a bankruptcy plan for the genetics-testing company once known as 23andMe agreed to dole out a total of $46.75 million to victims in a deal to end litigation st...
VT, NY, NH to receive settlements from 23andMe data breach
Vermont, New York, and New Hampshire will receive part of an $18 million settlement from 23andMe for failing to keep customers' genetic safe.
Judge Approves $46.75 Million Payout for 23andMe Data Breach Victims
A U.S. bankruptcy judge on July 7 approved a $46.75 million settlement for victims of a 2023 data breach at the genetic testing company 23andMe, which exposed genetic and other per...
California Cannot Seek Damages From 23andMe Successor Over 2023 Data Breach
A U.S. bankruptcy judge on July 10 said California cannot seek damages from the company formerly known as 23andMe arising from a 2023 data breach that exposed genetic and other per...
Pomerantz LLP Notifies Investors of Class Action Against GeneDx Holdings Corp. – WGS
Pomerantz LLP Informs Shareholders of Securities Class Action Against GeneDx Holdings Corp. – WGS
Pomerantz LLP Informs Shareholders of Class Action Filing Against GeneDx Holdings Corp. – WGS
Pomerantz LLP Informs Shareholders of Class Action Against GeneDx Holdings Corp. – WGS
Pomerantz LLP Informs Investors of Class Action Filing Against GeneDx Holdings Corp. – WGS
A genome-first multiomic approach to diagnosis
Did you know that one in 10 Americans have a rare disease and it can take five or more years, on average, for a person with a rare disease to get an accurate diagnosis? That’s more...
Chatting with my DNA – a fascinating personal use case and a deep rabbit hole
This one has nothing to do with running a company. But it’s one of the most fascinating things I’ve done with AI, and I fell down such a deep rabbit hole that I have to share it. M...
This Healthcare Investor Added $43 Million to a Genomics Leader Growing Volume 34%
GeneDx Holdings delivers AI-powered clinical and genomic data analysis for healthcare providers seeking precision medicine solutions.
My father died of cancer at 72. A $12,000 longevity exam at a Silicon Valley clinic found both good and bad news in my D...
I enrolled in Human Longevity's executive health program. My cancer results were reassuring, but my genetic results left me a little unsettled.
Two things my DNA told me that eleven years of blood tests never could
Genetic sequencing revealed unique responses to rosuvastatin medication for Nickhil Jakatdar. His body processes the statin more slowly than average, influencing future treatment d...
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.